Navigation Links
Curemark to Present at the Rodman & Renshaw Annual Global Investment Conference
Date:8/16/2010

.  In addition to healthcare, the conference will highlight industry tracks including China, metals and mining, energy, technology, cleantech, community and regional banks, and REITs.

About CUREMARK LLC

Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of protein digestion in children with autism and ADHD. To learn more about our innovative science, visit www.curemark.com.

Safe Harbor Statement

This news release contains forward-looking statements that involve risks and uncertainties that could cause our actual results and experiences to differ materially from anticipated results and expectations expressed in such forward-looking statement. These forward-looking statements include, without limitation, statements regarding the mechanism of action of CM-AT, its potential advantages, its potential for use in treating autism, as well as the timing, progress and anticipated results of the clinical development and regulatory processes concerning CM-AT. These statements are based on our current beliefs and expectations as to such future outcomes, and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a material difference include, among others, risks that the results of clinical trials will not support our claims or beliefs concerning the effectiveness of CM-AT, our ability to finance our development of CM-AT, regulatory risks, and our reliance on third party researchers and other collaborators. We assume no obligation to update these statement
'/>"/>

SOURCE Curemark, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Curemark Opens Autism Trials at New Jersey Site
2. Curemark Begins Autism Trials at Two More Sites
3. Dr. Joan Fallon, Curemark CEO, Addresses Keystone Symposia Meeting On Autism
4. Curemark Adds UC Davis MIND Institute to Autism Clinical Trial Sites
5. Curemark CM-AT Autism Treatment Granted FDA Fast Track Status
6. Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites
7. Curemark Opens Patient Enrollment for Autism Treatment at Three More Clinical Trial Sites
8. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
9. Curemark Announces Senior Executive Promotions
10. Curemark CEO Presents at Epigenomics Conference
11. Curemark Closes Series A Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 Since last month,s FBI shutdown ... known as the leading online black market for illegal ... in its offering of drugs and other illegal items.  ... takedowns did succeed in lowering the numbers of drugs ... the markets in August. But some new sites that ...
(Date:12/17/2014)... SAN DIEGO , Dec. 17, 2014 ... and Volcano Corporation (NASDAQ: VOLC ), a global ... today announced that they have entered into a definitive merger ... offer to acquire all of the issued and outstanding shares ... equity purchase price of USD 1 billion (approx. EUR 800 ...
(Date:12/17/2014)... 17, 2014  Northstar Global Business Services, Inc. ... (DTC) has made their final decision and has ... Company,s stock effective December 15, 2014, and has ... depository and book entry transfer services. All deposit restrictions ... once again fully "DTC Eligible", and has resumed ...
Breaking Medicine Technology:Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3
... March 11, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... of medical devices worldwide, today announced that it will present ... be held from March 21st to 25th at the Conrad ... Mr. Ronald Ede, Chief Financial Officer; Ms. May Li, Director ...
... 2011 Sanofi-aventis (EURONEXT: SAN and NYSE: ... REGN ) today announced results from the ... (VEGF Trap) for the second-line treatment of non-small cell ... to the chemotherapy drug docetaxel did not meet the ...
Cached Medicine Technology:Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer 2Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer 3Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer 4Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer 5Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer 6Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer 7
(Date:12/21/2014)... Parker & Sons, Inc. a market leader ... other similar home contractor services announces a record number ... expert contracting services. The company is considered by many ... Arizona for well over 40 years. Parker and Sons ... quality customer service to the residents and business owners ...
(Date:12/21/2014)... 2014 As testosterone therapy lawsuit ... stroke and blood clots from using testosterone products such ... study shows that the male hormone testosterone may increase ... study published in the Proceedings of the National Academy ... a group of male rats with naturally occurring colon ...
(Date:12/20/2014)... BambooIndustry.com is a professional company offering many kinds ... shown its new engineered bamboo flooring collection, and announced ... , BambooIndustry.com’s customers come from many countries in the ... the CEO of the company, the global bamboo flooring ... few years, and the demand for eco-friendly bamboo flooring ...
(Date:12/20/2014)... An improving macroeconomic landscape and a ... Massage Services industry over the five years ... the anticipated 1.0% annualized increase in per capita disposable ... the means to afford additional massages. “While the share ... a given year has declined from 2009 to 2012, ...
(Date:12/20/2014)... holidays can be anything but joyous for people with ... and other allergy triggers. "The dust from the ... away in dank basements or dusty attics is triggering ... Shah, an affiliate faculty member at Loyola University Chicago ... Shah, who is also an allergist at Gottlieb ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Holiday Trimmings Can Trigger Allergies 2
... Urges Enrollment, LOS ANGELES, Oct. 3 For ... trials are being conducted to seek a,treatment, perhaps even ... disease that affects more than 1.5 million Americans -- ... that clinical trials answer is, "Will this drug help,people ...
... service, ... sacrifice and innovation, LOS ANGELES, ... healthcare heroes, Cherokee Uniforms announced today,10 winners of the 2007 ... winners represent a cross-section of,healthcare facilities, from VA medical centers ...
... Foundation for,AIDS Research, today announced several key appointments to ... Kenneth Cole named Sharon Stone to the position,of Global ... Diana L. Taylor to the Foundation,s Board of Trustees. ... performer and,humanitarian Harry Belafonte and Edward L. Milstein, a ...
... Findings Underscore Need for Medicare Market Basket Update;,MedPAC ... Funding,Requirements, WASHINGTON, Oct. 3 The Alliance ... BDO Seidman study of the nation,s,Medicaid program released ... worsening problem: Medicare,s cross-subsidization of increasingly,inadequate Medicaid payments ...
... National Strategic Partnership will help others live their ... raising awareness of diabetes,and important life-planning issues, ... (ADA) today announced that the Dignity Memorial,network, North ... to fighting diabetes as the ADA,s new National ...
... the life science industry has grown by leaps and ... can be daunting. Career Opportunities in Biotechnology and ... Spring Harbor Laboratory Press ( www.cshlpress.com ), provides an ... on tailoring a job search, and guidance on making ...
Cached Medicine News:Health News:Clinical Trials for Lupus Underway After Decades of Drought 2Health News:National 'Cherokee Inspired Comfort Award' Winners Announced 2Health News:National 'Cherokee Inspired Comfort Award' Winners Announced 3Health News:National 'Cherokee Inspired Comfort Award' Winners Announced 4Health News:National 'Cherokee Inspired Comfort Award' Winners Announced 5Health News:amfAR Appoints New Leadership as AIDS Research Organization Extends Its Global Reach 2Health News:amfAR Appoints New Leadership as AIDS Research Organization Extends Its Global Reach 3Health News:amfAR Appoints New Leadership as AIDS Research Organization Extends Its Global Reach 4Health News:New Study Spotlights Growing Role of Medicare in Propping Up Nation's Medicaid Program 2Health News:American Diabetes Association Announces Three Year Collaboration With The Dignity Memorial(R) Network 2Health News:American Diabetes Association Announces Three Year Collaboration With The Dignity Memorial(R) Network 3Health News:The hottest jobs in science, and how to land them 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: